Literature DB >> 6284091

Neutralising antibody in mice with primary and recurrent herpes simplex virus infection.

J M Darville, W A Blyth.   

Abstract

Neutralising antibody was studied in mice infected in the ear with herpes simplex virus type 1. Antibody was detected six days after infection and after one month it had reached titres which subsequently varied little. Geometric group mean titres were doubled by reinoculation of virus whereas recurrent disease induced by trauma did not change them (although titres did change in some individual animals). Mean titres in mice which had had unequivocal signs of primary disease were twice as high as in those which had not, and the frequency of recurrent disease in response to trauma in the former animals was greater than in the latter. A reduction in the frequency of induced recurrent disease was seen if the application of trauma was delayed for some time after the establishment of latency. Hyperimmunisation increased mean titres tenfold. If given soon after primary infection it reduced the frequency of induced recurrent disease but if its administration was delayed then the frequency was increased.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284091     DOI: 10.1007/bf01315060

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Direct lymphocytotoxicity against herpes simplex virus infected cells.

Authors:  Y Fujimiya; L A Babiuk; B T Rouse
Journal:  Can J Microbiol       Date:  1978-09       Impact factor: 2.419

2.  Herpes simplex virus type-1 and human lymphocytes: virus expression and the response to infection of adult and foetal cells.

Authors:  D Westmoreland
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

3.  Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.

Authors:  Y H Thong; M M Vincent; S A Hensen; D A Fuccillo; M Rola-Pleszczynski; J A Bellanti
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Herpesvirus hominis infections in renal transplant recipients.

Authors:  B Korsager; E S Spencer; C H Mordhorst; H K Andersen
Journal:  Scand J Infect Dis       Date:  1975

Review 5.  Herpes simplex infections in hematologic malignancies.

Authors:  S A Muller; E C Herrmann; R K Winkelmann
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

6.  Acute and recurrent herpes simplex in several strains of mice.

Authors:  D A Harbour; T J Hill; W A Blyth
Journal:  J Gen Virol       Date:  1981-07       Impact factor: 3.891

7.  Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.

Authors:  C A Daniels; S G LeGoff
Journal:  Lancet       Date:  1975-09-20       Impact factor: 79.321

8.  Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation.

Authors:  T Sekizawa; H Openshaw; C Wohlenberg; A L Notkins
Journal:  Science       Date:  1980-11-28       Impact factor: 47.728

9.  Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.

Authors:  C Lopez; R J O'Reilly
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

10.  Human neutrophil--mediated destruction of antibody sensitized herpes simplex virus type I infected cells.

Authors:  Y Fujimiya; B T Rouse; L A Babiuk
Journal:  Can J Microbiol       Date:  1978-02       Impact factor: 2.419

View more
  4 in total

1.  The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus.

Authors:  D M Altmann; W A Blyth
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

2.  Cell-mediated immunity in mice with primary, secondary and latent herpes simplex virus infection.

Authors:  J M Darville; W A Blyth
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Lipopolysaccharide-induced suppressor cells for delayed-type hypersensitivity to herpes simplex virus: nature of suppressor cell and effect on pathogenesis of herpes simplex.

Authors:  D M Altmann; W A Blyth
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

4.  Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.

Authors:  R F Schinazi; J Peters; M K Sokol; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.